Amneal shares rise after UBS initiates at Buy, cites “best-in-group” growth in specialty pharma

Amneal Pharmaceuticals Inc (NASDAQ:AMRX) shares rose 5.7% on Friday after UBS initiated coverage with a Buy rating and a $19 price target, citing what it...